Light-activated Protein Used to Improve Mitochondrial Function, Reduce Parkinson’s Symptoms in Fly Study

Light-activated Protein Used to Improve Mitochondrial Function, Reduce Parkinson’s Symptoms in Fly Study
Using a light-activated protein to improve the function of mitochondria — cells’ powerhouses— could be a therapeutic strategy for Parkinson’s disease (PD), a new study done in flies suggests. The results of the study, “Light-driven activation of mitochondrial proton-motive force improves motor behaviors in a Drosophila model of Parkinson’s disease,” were published in Communications Biology. Mitochondria are organelles —specialized structures ... read more
Source: Parkinson’s News TodayPublished on 2020-02-17By Marisa Wexler